Report of Foreign Issuer (6-k)
June 27 2019 - 7:36AM
Edgar (US Regulatory)
UNITED STATES
SECURITIES
AND EXCHANGE COMMISSION
W
ashington,
D.C.
20549
FORM 6-K
Report of Foreign Private Issuer
Pursuant to Rule 13a-16 or 15d-16
of the Securities Exchange Act of
1934
For the month of June 2019
Commission File Number: 001-37643
KITOV PHARMA
LTD.
(Translation of registrant’s name
into English)
One Azrieli Center, Round Tower,
132 Menachem Begin Road, Tel Aviv 6701101,
Israel
(Address of principal executive offices)
Indicate by check mark
whether the registrant files or will file annual reports under cover Form 20-F or Form 40-F.
Form 20-F ☒
Form 40-F ☐
Indicate by check mark
if the registrant is submitting the Form 6-K in paper as permitted by Regulation S-T Rule 101(b)(1): ____
Indicate by check mark
if the registrant is submitting the Form 6-K in paper as permitted by Regulation S-T Rule 101(b)(7): ____
Kitov Pharma
Ltd.
(the “Company” or the “Registrant”) is announcing that on June 27, 2019, the Company issued a press release
“
Kitov Successfully Completes IND-enabling Studies to advance NT219 for the Treatment of Patients with Recurrent or Metastatic
Head and Neck Cancers
,” which is attached hereto as Exhibit 99.1.
This
Form 6-K, including Exhibit 99.1, is incorporated by reference into each of the Registrant’s Registration Statements on Form
F-3 filed with the Securities and Exchange Commission on December 12, 2016 (Registration file numbers 333-207117, 333-211477 and
333-215037), the Registrant’s Registration Statement on Form S-8 filed with the Securities and Exchange Commission on May
20, 2016 (Registration file number 333-211478), the Registrant’s Registration Statement on Form S-8 filed with the Securities
and Exchange Commission on June 6, 2017 (Registration file number 333-218538), the Registrant’s Registration Statement on
Form F-3, as amended, originally filed with the Securities and Exchange Commission on July 16, 2018 (Registration file number 333-226195),
and the Registrant’s Registration Statement on Form S-8 filed with the Securities and Exchange Commission on March 28, 2019
(Registration file number 333-230584).
SIGNATURES
Pursuant to the requirements
of the Securities Exchange Act of 1934, the Registrant has duly caused this report to be signed on its behalf by the undersigned,
thereunto duly authorized.
|
KITOV PHARMA LTD.
|
|
|
|
June 27, 2019
|
By:
|
/s/ Isaac Israel
|
|
|
Isaac Israel
|
|
|
CEO & Director
|
2
Kitov Pharma (NASDAQ:KTOV)
Historical Stock Chart
From Aug 2024 to Sep 2024
Kitov Pharma (NASDAQ:KTOV)
Historical Stock Chart
From Sep 2023 to Sep 2024